Study to establish the indication for the selective S2 antagonist ritanserin

Area of Science:

• Psychiatry
• Pharmacology

Background:

• Ritanserin is an antidepressant medication.
• Previous studies have reported varying results regarding its efficacy and side effect profile.

Purpose of the Study:

• To evaluate the efficacy and tolerability of ritanserin as an antidepressant.
• To investigate ritanserin's effects in patients with melancholia and depressive schizophrenia.

Main Methods:

• An open study design was employed.
• Patients with depression, including melancholia and schizophrenia, were treated with ritanserin.

Main Results:

• Ritanserin showed a rapid onset of antidepressant action with a low incidence of side effects.
• The drug was effective in patients with melancholia.
• Ritanserin improved mood and well-being in depressive schizophrenic patients when used as supplementary therapy with neuroleptics.
• Psychotic symptoms were provoked in schizophrenic patients, similar to amitriptyline, despite lacking anticholinergic effects.

Conclusions:

• Ritanserin is a well-tolerated antidepressant with a rapid onset of action.
• It is effective for melancholic depression and can be beneficial for depressive schizophrenic patients as an add-on therapy.
• The study's findings are limited by intensive patient care and high patient expectations.